Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-04-24
Original SEC Filing: Click here

---

Webplus: BSPM/20120424/8-K/2_EX-10.1/000.htm SEC Original: ex10-1.htm
Amendment No. 1 to the Employmentreement th This Amendment No. 1 (the Amendment) to Employmentreement is made of this 20 WITNESSETH WHEREAS WHEREAS WHEREAS NOW THEREFORE 2. Term 1.Paragraph 2.Inl other respects, the provisions of the Employmentreement restated remain unchanged and in full force and effect.

---

---

Webplus: BSPM/20120424/8-K/1/000.htm SEC Original: biostarpharma8k042312.htm
FORM 8-K CURRENT REPORT April 20, 2012te of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Xi Avenue Xianyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-04-24CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046